Neurology.

Intro -- Title Page -- Copyright Page -- Contents -- Contributors -- Series Foreword -- Preface -- List of Abbreviations -- About the Companion Website -- Part 1 Introduction -- Chapter 1 Neurologic History and Examination -- Overview -- Approach to history taking for the neurologic patient -- Approach to the neurologic examination -- Mental status -- Cranial nerves -- Motor examination -- Sensory examination -- Reflexes -- Gait and coordination (Box 1.3) -- Reading list -- Chapter 2 Neuroradiology -- Introduction -- Imaging of cerebral ischemia -- Imaging of parenchymal hemorrhage -- Overview of intracranial vasculature -- Safety concerns with MRI -- Conclusions -- Images -- Reading list -- Chapter 3 Neurophysiologic and Other Neurodiagnostic Tests -- Nerve conduction studies (NCS) and electromyography (EMG) -- Nerve conduction studies (NCS) -- Special tests: blink reflex and repetitive nerve stimulation -- Electromyography -- Electroencephalography -- Evoked potentials -- Neuromuscular ultrasound -- Carotid and transcranial ultrasound -- Conclusions -- Reading list -- Part 2 Diagnosis of Patients with Neurologic Symptoms -- Chapter 4 Delirium and Coma -- Background -- Approach to diagnosis -- Recommended diagnostic strategy (Algorithm 4.1) -- Reading list -- Chapter 5 Episodic Collapse, Loss of Consciousness, Seizures -- Background -- Approach to diagnosis -- Recommended diagnostic strategy -- Reading list -- Chapter 6 Dysphasias, Dyspraxias, and Dysexecutive Syndromes: The Non-Memory Cognitive Impairments -- Background -- Approach to diagnosis -- Recommended diagnostic strategy -- Images -- Reading list -- Chapter 7 Memory Loss and Dementia -- Background -- Approach to diagnosis -- Recommended diagnostic strategy -- Acknowledgement -- Reading list -- Acknowledgement -- Chapter 8 Headache -- Background -- Approach to diagnosis.

Recommended diagnostic strategy -- Reading list -- Chapter 9 Abnormal Movements and Incoordination -- Background -- Approach to diagnosis -- Recommended diagnostic strategy -- Images -- Reading list -- Chapter 10 Sleep Disorders, Somnolence, and Fatigue -- Background -- Approach to diagnosis -- Reading list -- Chapter 11 Visual Loss and Double Vision -- Background -- Approach to diagnosis -- Table of frequency of each disease -- Images -- Reading list -- Chapter 12 Vertigo, Dizziness, and Hearing Loss -- Background -- Approach to diagnosis -- Recommended treatment strategy -- Reading list -- Chapter 13 Facial Weakness, Slurred Speech, and Difficulty Swallowing -- Background -- Approach to diagnosis -- Reading list -- Chapter 14 Difficulty Walking -- Background -- Approach to diagnosis -- Recommended diagnostic strategy -- Reading list -- Chapter 15 Muscle Weakness and Paralysis -- Background -- Approach to diagnosis -- Recommended diagnostic strategy -- Reading list -- Chapter 16 Tingling and Loss of Sensation -- Background -- Approach to diagnosis -- Reading list -- Chapter 17 Low Back Pain and Neck Pain -- Background -- Approach to diagnosis -- Reading list -- Chapter 18 Suspected Spinal Cord Dysfunction -- Background -- Approach to diagnosis -- Reading list -- Chapter 19 Bladder and Sexual Dysfunction -- Section 1: Bladder dysfunction -- Section 2: Sexual dysfunction -- Reading list -- Part 3 Neurologic Diseases and Therapeutics -- Chapter 20 Vascular Diseases: Ischemic Stroke, Intracerebral and Subarachnoid Hemorrhage, Cerebral Venous Thrombosis, Arterio-Venous Malformations -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment (Algorithm 20.1) -- Section 5: Special populations (Figures 20.1, 20.2, and 20.3) -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines.

Section 9: Evidence -- Section 10: Images -- Chapter 21 Neurologic Complications of Systemic Disease -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Chapter 22 Neuro-Oncology -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Chapter 23 Multiple Sclerosis and Other Inflammatory Diseases -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Chapter 24 Infections of the Nervous System -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Chapter 25 Parkinson's Disease and Related Disorders -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment (Algorithm 25.1) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence for therapies -- Chapter 26 Hyperkinetic Movement Disorders -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment (Algorithms 26.1-26.3) -- Section 5: Special populations -- Section 6: Prognosis -- Chapter 27 Alzheimer's Disease and Frontotemporal Dementia -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis.

Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence for effectiveness of therapies -- Section 10: Images -- Chapter 28 Cerebellar and Brainstem Disorders -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis, etiology, and treatment (Algorithms 28.1 and 28.2) -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Chapter 29 Inborn Errors of Metabolism -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence for therapies -- Chapter 30 Epilepsy -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Chapter 31 Autonomic Disorders -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment (Algorithm 31.2) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence for therapies -- Section 10: Images -- Chapter 32 Peripheral Neuropathies -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment (Algorithm 32.6) -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Chapter 33 Myopathy -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Chapter 34 Neuromuscular Junction Disorders -- Section 1: Background.

Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence for therapies -- Chapter 35 Motor Neuron Disease -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence for therapies -- Chapter 36 Metabolic Encephalopathy, Hypoxic-Ischemic Encephalopathy, and Brain Death -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Chapter 37 Pain Disorders -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Chapter 38 Migraine and Other Headache Disorders -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Chapter 39 Sleep Disorders -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines -- Section 9: Evidence for therapies -- Chapter 40 Neurocritical Care -- Section 1: Background -- Section 2: Prevention and screening -- Section 3: Diagnosis -- Section 4: Treatment -- Section 5: Special populations -- Section 6: Prognosis -- Section 7: Reading list -- Section 8: Guidelines.

Section 9: Evidence for therapies.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.